Biotechnology organisations often grapple with three key trends – where the next round of funding will come from, how to attract specialised talent to support vital innovation, and how to tackle manufacturing and scale up. They seek stability and certainty in funding to ensure projects are supported and reach their full potential. How can the upcoming Federal Budget announcement better support this sector?
We’re currently experiencing a veritable shopping list of headwinds – inflation, interest rates, labour costs, fuel prices, and supply chain challenges – applying pressure on businesses across all industries. The need to balance cost control with sustainable growth is a fine needle to thread, and not all businesses and costs are created equal. With so many cost control levers to pull, as a CFO, where do you begin?
Frances Carter has always been passionate about sustainability and the environment, and today she helps clients at Conservation Capital understand the importance of commercial conservation and why it is their responsibility to be corporate stewards.
In the fast-moving ESG (Environmental, Social and Governance) movement, the last few years have seen a proliferation of sustainability reporting frameworks all intended to help organisations make meaningful disclosures in relation to sustainability and other non-financial information.